Загрузка...
The Effect of Sodium Channel Blocker, Mexiletine, on Body Weight in Type 2 Diabetes Patients with Visceral Obesity
OBJECTIVE: Mexiletine is an anti-arrhythmic agent also used for the treatment of painful diabetic neuropathy. In this study, the effect of mexiletine on body weight was evaluated in type 2 diabetes patients with diabetic neuropathy exhibiting visceral obesity. METHODS: Type 2 diabetes patients with...
Сохранить в:
| Опубликовано в: : | Clin Med Insights Endocrinol Diabetes |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343451/ https://ncbi.nlm.nih.gov/pubmed/30733634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179551418825049 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|